Gain Therapeutics's total assets for Q1 2026 were $18.74M, a decrease of -17.88% from the previous quarter. GANX total liabilities were $4.73M for the fiscal quarter, a 11.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.